MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of May 2019 and reports on the results of MediWound Ltd.'s annual general meeting of shareholders held on May 2, 2019. The Company is a foreign private issuer based in Yavne, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document details the successful approval of seven shareholder proposals previously outlined in the proxy statement filed on March 25, 2019.
Outlook, Risks, and Management Commentary
Management commentary is limited to the confirmation that all seven proposals were approved based on voting results and majority requirements under Israeli law. No specific guidance, outlook, risks, contingencies, or unusual items are disclosed in this text.
Key Facts for Investor Verification
- Shareholder Participation: 16,368,399 ordinary shares were present in person or by proxy, representing 60.2% of the 27,178,839 shares outstanding as of the March 29, 2019 record date.
- Voting Outcome: All seven proposals presented at the annual general meeting were approved.
- Quorum Status: The meeting was properly convened with a quorum present under the Company's Articles of Association.
- Reference Document: Details regarding the specific proposals are contained in the proxy statement attached as Exhibit 99.1 to the Form 6-K filed on March 25, 2019.